Dr. Robert Frank Cubas, MD

Dr. Cubas practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Cubas' NPI, 1407114382, was assigned on April 27, 2012. Dr. Cubas graduated from Universidad Nacional de Cordoba in 2004. Dr. Cubas holds Florida license ME140376.

Dr. Cubas' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Cubas' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Cubas is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Cubas to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cubas practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Cubas' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Cubas is board certified in obesity medicine by the American Board of Obesity Medicine. Dmand AI has Dr. Cubas' licenses on file in 2 states: Florida and California.

Dmand AI lists abdominal adhesion surgery, colonoscopy, gallbladder removal, gastrointestinal obstruction, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Cubas treats.

CMS data shows 64 Medicare services from Dr. Cubas across 3 procedure codes in 2024, for 93 Medicare patients. Medicare paid $4,444 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Cubas in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cubas' median patient age at 66, with 60% women.

In 2024, Dr. Cubas wrote 124 Medicare Part D claims for 51 patients. 95% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $110 in total drug cost. In 2022, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cubas for performance year 2024, reported as part of a group. Dr. Cubas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cubas as offering telehealth. CMS counts 15 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Cubas, more than 46% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Cubas, published from 2012 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Laparoscopy, Robotic Surgical Procedures and Endoscopy. Dr. Cubas has published most often in Rev Fac Cien Med Univ Nac Cordoba. Dr. Cubas' most frequent co-authors are Ryan C. Broderick, MD, Joslin Nicolle Cheverie, MD and Santiago Horgan.

CMS Open Payments shows 105 general payments to Dr. Cubas from 15 drug and device companies from 2018 to 2025. Grants make up the largest share, 63% of the total. Boston Scientific Corporation paid the most, $17,447.

Dmand AI lists 3 awards for Dr. Cubas, most recently Fellow (FACS) in 2022. Dr. Cubas serves on Fundamentals of Endoscopic Surgery SAGES Committee.

Dr. Cubas graduated from Universidad Nacional de Cordoba in 2004. Dr. Cubas is a member of ACS, AMA, ASMBS and SAGES.

Dr. Cubas is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.